Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M

Reuters

Aug 01

Performant Healthcare Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M

Performant Healthcare, Inc. (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2556040815"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2556040815\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2556040815?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-01 20:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556040815","market":"fut","top_or_hot":-1,"title":"Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Performant Healthcare Reports <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PHLT\">Performant Healthcare, Inc.</a> (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPerformant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-01 20:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Performant Healthcare Reports <a href=\"https://laohu8.com/S/QTWO\">Q2</a> 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PHLT\">Performant Healthcare, Inc.</a> (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHLT","symbol_name":"Performant Healthcare, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL2FYwc9:1","article_id":"2556040815","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556040815","pubTimestamp":1754051718,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Performant Healthcare, Inc.  has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial,","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"PHLT":"Performant Healthcare, Inc."},"translate_title":"Performant Healthcare报告2025年第二季度收入为3780万美元，净利润为210万美元；调整后EBITDA为620万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHLT":0.9},"content_text":"Performant Healthcare Reports Q2 2025 Revenue of $37.8M and Net Income of $2.1M; Adjusted EBITDA at $6.2M\n    \n\nPerformant Healthcare, Inc. (Nasdaq: PHLT) has announced its preliminary financial results for the second quarter of 2025. The company anticipates reporting revenues of approximately $37.8 million and a net income of about $2.1 million. Additionally, Performant expects an adjusted EBITDA of roughly $6.2 million for the quarter ended June 30, 2025. In a separate announcement, Performant disclosed its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio company of New Mountain Capital. Consequently, Performant has canceled its second quarter results conference call that was originally scheduled for August 5, 2025, and has withdrawn its previously issued full-year 2025 guidance.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250801947280) on August 01, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}